Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31

被引:42
|
作者
Chang, YJE
Pena, L
Sen, GC
Park, JK
Laimins, LA
机构
[1] Northwestern Univ, Fineberg Med Sch, Dept Microbiol Immunol, Chicago, IL 60611 USA
[2] Northwestern Univ, Fineberg Med Sch, Dept Pathol, Chicago, IL 60611 USA
[3] Cleveland Clin Fdn, Dept Mol Biol, Cleveland, OH 44195 USA
关键词
D O I
10.1128/JVI.76.17.8864-8874.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The long-term effects of interferon treatment on cell lines that maintain human papillomavirus type 31 (HPV-31) episomes have been examined. High doses and prolonged interferon treatment resulted in growth arrest of HPV-positive cells, with a high percentage of cells undergoing apoptosis. These effects were not seen with interferon treatment of either normal human keratinocytes or cells derived from HPV-negative squamous carcinomas, which exhibited only slight decreases in their rates of growth. Within 2 weeks of the initiation of treatment, a population of HPV-31-positive cells that were resistant to interferon appeared consistently and reproducibly. The resistant cells had growth and morphological characteristics similar to those of untreated cells. Long-term interferon treatment of HPV-positive cells also resulted in a reduction in HPV episome levels but did not significantly decrease the number of integrated copies of HPV. Cells that maintained HPV genomes lacking E5 were sensitive to interferon, while cells expressing only the E6/E7 genes were resistant. In contrast, cells that expressed E2 from a tetracycline-inducible promoter were found to be significantly more sensitive to interferon treatment than parental cells. This suggests that at least a portion of the sensitivity to interferon could be mediated through the E2 protein. These studies indicate that cells maintaining HPV episomes are highly sensitive to interferon treatment but that resistant populations arise quickly.
引用
收藏
页码:8864 / 8874
页数:11
相关论文
共 50 条
  • [1] Long-term maintenance of human keratinocytes in vitro
    Hasskarl, J
    Velupillai, P
    Piboonniyom, SO
    Grace, M
    Münger, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (02) : 475 - 478
  • [2] Long-term efficacy of human papillomavirus vaccination
    Ault, Kevin A.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : S27 - S30
  • [3] Long-term persistence of human papillomavirus in environments
    Ding, Dah-Ching
    Chang, Ying-Cheng
    Liu, Hwan-Wun
    Chu, Tang-Yuan
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : 148 - 151
  • [4] Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription
    Ozbun, MA
    JOURNAL OF VIROLOGY, 2002, 76 (22) : 11291 - 11300
  • [5] GAMMA-INTERFERON EFFECT IN HUMAN MARROW LONG-TERM CULTURE
    CHIANG, KY
    LASKY, LC
    ZANIANI, ED
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 553 - 553
  • [6] Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate
    Patterson, NA
    Smith, JL
    Ozbun, MA
    JOURNAL OF VIROLOGY, 2005, 79 (11) : 6838 - 6847
  • [7] Long-term expansion of primary equine keratinocytes that maintain the ability to differentiate into stratified epidermis
    Faris Alkhilaiwi
    Liqing Wang
    Dan Zhou
    Terje Raudsepp
    Sharmila Ghosh
    Siddartha Paul
    Nancy Palechor-Ceron
    Sabine Brandt
    Jennifer Luff
    Xuefeng Liu
    Richard Schlegel
    Hang Yuan
    Stem Cell Research & Therapy, 9
  • [8] Long-term expansion of primary equine keratinocytes that maintain the ability to differentiate into stratified epidermis
    Alkhilaiwi, Faris
    Wang, Liqing
    Zhou, Dan
    Raudsepp, Terje
    Ghosh, Sharmila
    Paul, Siddartha
    Palechor-Ceron, Nancy
    Brandt, Sabine
    Luff, Jennifer
    Liu, Xuefeng
    Schlegel, Richard
    Yuan, Hang
    STEM CELL RESEARCH & THERAPY, 2018, 9
  • [9] Human papillomavirus and the long-term risk of cervical neoplasia
    van der Graaf, Y
    Molijn, A
    Doornewaard, H
    Quint, W
    van Doorn, LJ
    van den Tweel, J
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (02) : 158 - 164
  • [10] Long-term efficacy and safety of human papillomavirus vaccination
    De Vincenzo, Rosa
    Conte, Carmine
    Ricci, Caterina
    Scambia, Giovanni
    Capelli, Giovanni
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2014, 6 : 999 - 1010